Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 07/19/2019

Closing price: 231.27

Support price level:	$221.85
Resistance price level:	$239.37
Relative strength index (14-day RSI)	45.4
Beta	1.21

With a -35.5 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 35.8%.
Volatility is forecast to fall over the next month.

Low	High	Price as % of Range
$216.71	$383.83	11.4%

200 day	50 day	20 day	10 day
$283.86	$230.91	$234.50	$231.86

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
37.2%	35.7%	35.8%	37.0%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: